Widely used:Recently Viewed
Clear All
Today’s Range
52 Week Range
Liquidity
Market cap
$12 Mln
P/E Ratio
--
P/B Ratio
1.54
Industry P/E
--
Debt to Equity
0.19
ROE
-2.66 %
ROCE
-187.6 %
Div. Yield
0 %
Book Value
--
EPS
--
CFO
$-63.60 Mln
EBITDA
$-88.54 Mln
Net Profit
$-84.79 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Vivos Therapeutics (VVOS)
| -51.05 | -36.36 | -64.71 | -22.22 | -65.00 | -- | -- |
|
BSE Sensex
| 0.39 | 6.40 | 1.96 | 7.69 | 10.43 | 20.75 | 10.61 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2024
|
2023
|
2022
|
2021
|
|
|---|---|---|---|---|
|
Vivos Therapeutics (VVOS)
| -65.21 | 23.78 | -82.13 | -61.93 |
|
S&P Small-Cap 600
| 7.01 | 13.89 | -17.42 | 25.27 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 15.10 | 10,391.68 | 14.66 | 12.69 | |
| 71.01 | 9,766.86 | 94.68 | 2.52 | |
| 277.35 | 10,728.90 | 770.42 | 1.2 | |
| 117.67 | 14,455.82 | 41.45 | 5.44 |
Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive,... non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Littleton, Colorado. Address: 7921 Southpark Plaza, Littleton, CO, United States, 80120 Read more
Co-Founder, Chairman of the Board & CEO
Mr. R. Kirk Huntsman
Co-Founder, Chairman of the Board & CEO
Mr. R. Kirk Huntsman
Headquarters
Littleton, CO
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Vivos Therapeutics Inc (VVOS) stood at $ 15 Mln as on 31-Dec-24
The share price of Vivos Therapeutics Inc (VVOS) is $2.10 (NASDAQ) as of 17-Apr-2025 16:00 EDT. Vivos Therapeutics Inc (VVOS) has given a return of -65% in the last 3 years.
Vivos Therapeutics Inc (VVOS) has a market capitalisation of $ 12 Mln as on 17-Apr-2025. As per Value Research classification, it is a Small Cap company.
Since, TTM earnings of Vivos Therapeutics Inc (VVOS) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Vivos Therapeutics Inc (VVOS) and enter the required number of quantities and click on buy to purchase the shares of Vivos Therapeutics Inc (VVOS).
Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Littleton, Colorado. Address: 7921 Southpark Plaza, Littleton, CO, United States, 80120
The CEO & director of Mr. R. Kirk Huntsman. is Vivos Therapeutics Inc (VVOS), and CFO & Sr. VP is Mr. R. Kirk Huntsman.
There is no promoter pledging in Vivos Therapeutics Inc (VVOS).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,126
|
|
|
1,070
|
|
|
1,049
|
|
|
978
|
| Vivos Therapeutics Inc. (VVOS) | Ratios |
|---|---|
|
Return on equity(%)
|
-266.25
|
|
Operating margin(%)
|
-74.32
|
|
Net Margin(%)
|
-74.09
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Vivos Therapeutics Inc (VVOS) was $0 Mln.
$0.02
(
